Legal Representation
Attorney
Brett M. Tolpin
USPTO Deadlines
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 23, 2018 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Apr 21, 2018 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 23, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2017 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Sep 22, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 20, 2017 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 5, 2017 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 20, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 5, 2017 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 7, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 10, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 10, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 21, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 1, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 1, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 1, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 1, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 9, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 9, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 9, 2016 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 9, 2016 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 9, 2016 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 9, 2016 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Mar 24, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 23, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 23, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 23, 2015 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Sep 23, 2015 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Sep 23, 2015 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Sep 18, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 15, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 13, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Over the counter horse care products, namely, vitamins and dietary supplements, and medicated lotions, gels, sprays, ointments and topical treatments for treating dermatological, muscular, inflammatory, respiratory and digestive conditions; over the counter horse care products, namely, electrolytes, electrolyte supplements, topical first aid sprays and gels, antispasmodics, muscle relaxants, muscle soaks, pharmaceutical products for treating respiratory diseases and conditions, respiratory stimulants, medicaments to help assist with the regeneration and reduction of inflammation of ligament and tendon fibers, pharmaceutical preparations for the prevention and treatment of disorders and conditions of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
First Use Anywhere:
Mar 1, 2015
First Use in Commerce:
Mar 18, 2016
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HORSE"